glp-1 drugs and alzheimer's Drug Fails to Quell in Novo Nordisk Trials GLP-1 Microdosing, Brain Health &

European Medicines Agency website

But there are some considerations to keep in mind before turning to weight loss drugs such as Ozempic, Wegovy, Mounjaro and Zepbound

Conversely, the LIRAFLAME trial failed to show a significant effect of liraglutide compared to placebo on vascular inflammation as assessed by [18F]FDG PET after 26 weeks of treatment in people with T2DM [140]

Patients who accept obesity as a chronic condition requiring ongoing management maintain weight loss successfully and report high satisfaction with outcomes

Thomsen C, Rasmussen O, Lousen T, et al

Pair this observation with actionable, mandatory resistance-training prescriptions to negate "failure to treat" liabilities